Tyra Biosciences, Inc. (TYRA) stock
TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$19.61+0.04 (+0.20%)
Close on Nov 18, 2026Market cap $1.17BP/E –Yield –
Tyra Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Tyra Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$109.65M. For fiscal 2025 it was -$95.14M. The highest annual figure on record is -$7.76M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$95.14M | – |
| FY2024 | Dec 31, 2024 | -$69.77M | – |
| FY2023 | Dec 31, 2023 | -$50.14M | – |
| FY2022 | Dec 31, 2022 | -$50.29M | – |
| FY2021 | Dec 31, 2021 | -$23.75M | – |
| FY2020 | Dec 31, 2020 | -$7.76M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$31.08M | – |
| Q1 FY2026 | Mar 31, 2026 | -$32.57M | – |
| Q4 FY2025 | Dec 31, 2025 | -$23.62M | – |
| Q3 FY2025 | Sep 30, 2025 | -$22.38M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.68M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.46M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.59M | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.90M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.26M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.53M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.15M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.62M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.85M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.21M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.17M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.68M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.53M | – |
See a number that looks wrong?